"Kalkine Media dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ...

Edwards Lifesciences (NYSE:EW) has been analyzed by 9 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The following table summarizes their ...

Truist lowered the firm’s price target on Edwards Lifesciences (EW) to $75 from $78 and keeps a Hold rating on the shares as part of a broad research note previewing Q1 results in Medical ...

Edwards Lifesciences has disclosed pay for CEO Bernard Zovighian in 2024, his first full year leading the company after the retirement of longtime Chair and CEO Mike Mussallem. The structural heart ...

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic ...

Edwards Lifesciences Corporation (EW), a $39.4 billion medical technology firm based in Irvine, California, specializes in cutting-edge solutions for structural heart disease and critical care ...

Donald Trump last night caved in to bond market pressure as he announced a 90-day pause on huge import tariffs. It came after US bond yields soared, sparking similar sell-offs across the globe.

The current offensive is aimed at “increasing the pressure on Hamas for the sake of releasing the hostages” and preparing the ground for Israel’s plan to “defeat Hamas,” Defense Minister ...

The competition for deposit mobilisation is likely to remain high even during FY26, which will limit banks’ ability to cut deposit rates. But on the other hand, lending rates may remain under pressure ...

In a tightly packed Western Conference, every contest has the potential to reshape the playoff picture, intensifying the pressure on every rotation and play. Reflections on a Journey of Promise ...